EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

JAK/STAT signaling in diabetic kidney disease

Yingjun Liu, Wenkuan Wang, Jintao Zhang, Shuo Gao, Tingting Xu, Yonghui Yin

Frontiers in Cell and Developmental Biology · 11.08.2023 · 11

DOI: 10.3389/fcell.2023.1233259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 11.08.2023. Verfasst von Yingjun Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Medicine Department, Shandong University of Traditional Chinese Medicine, Jinan, China. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is the most important microvascular complication of diabetes and the leading cause of end-stage renal disease (ESRD) worldwide. The Janus kinase/signal transducer and activator of the transcription (JAK/STAT) signaling pathway, which is out of balance in the context of DKD, acts through a range of metabolism-related cytokines and hormones. JAK/STAT is the primary signaling node in the progression of DKD. The latest research on JAK/STAT signaling helps determine the role of this pathway in the factors associated with DKD progression. These factors include the renin–angiotensin system (RAS), fibrosis, immunity, inflammation, aging, autophagy, and EMT. This review epitomizes the progress in understanding the complicated explanation of the etiologies of DKD and the role of the JAK/STAT pathway in the progression of DKD and discusses whether it can be a potential target for treating DKD. It further summarizes the JAK/STAT inhibitors, natural products, and other drugs that are promising for treating DKD and discusses how these inhibitors can alleviate DKD to explore possible potential drugs that will contribute to formulating effective treatment strategies for DKD in the near future.

Schlagwörter

Stichwörter der Autor:innen

JAK/STAT signalingdiabetic kidney diseaseetiologyinhibitortreatment strategy

Autor:innen und Institutionen

  • Clinical Medicine Department, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Endocrinology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Zitieren

APA

Liu, Y., Wang, W., Zhang, J., Gao, S., Xu, T., & Yin, Y. (2023). JAK/STAT signaling in diabetic kidney disease. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1233259

Vancouver

Liu Y, Wang W, Zhang J, Gao S, Xu T, Yin Y. JAK/STAT signaling in diabetic kidney disease. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1233259

BibTeX
@article{Liu2023,
  author = {Liu, Yingjun and Wang, Wenkuan and Zhang, Jintao and Gao, Shuo and Xu, Tingting and Yin, Yonghui},
  title = {JAK/STAT signaling in diabetic kidney disease},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2023},
  volume = {11},
  doi = {10.3389/fcell.2023.1233259}
}
Kostenlos starten →